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Coherent splicing networks arise from many discrete splicing decisions regulated in unison. Here,
we examine the properties of robust, context-specific splicing networks. We propose that a subset
of key splicing regulators, or ‘‘master splicing factors,’’ respond to environmental cues to establish
and maintain tissue transcriptomes during development.Design Principles of Robust Splicing Networks
The epigenetic landscape of differentiation defined by Conrad
Waddington nearly 60 years ago proposed that homeostatic
mechanisms maintained multiple irreversible cell states, pro-
viding an early suggestion that both stability and plasticity
were critical components of biological networks (Waddington,
1957). While ensuing efforts focused on understanding the role
of transcriptional programs in homeostasis or differentiation,
the importance of the posttranscriptional contribution to these
processes is now reaching the forefront. Several recent lines
of evidence suggest that splicing networks are composed of
highly interconnected events, conferring stability to the system
while simultaneously maintaining responsiveness to external
stimuli. This is the definition of a ‘‘robust’’ network (Kitano,
2004). Along with transcriptional and other posttranscriptional
effects, splicing contributes a layer of regulation integral to the
establishment of tissue transcriptomes.
Though nearly all mammalian genes undergo alternative
splicing (AS) in some context (Wang et al., 2008), only a minor-
ity of splicing events are conserved across evolution; never-
theless, this population has provided critical insights into
the role of AS in gene networks (Barbosa-Morais et al.,
2012; Merkin et al., 2012). Most conserved splicing events
tend to maintain reading frame and encode alternative protein
variants (Barbosa-Morais et al., 2012; Merkin et al., 2012).
However, a substantial fraction of conserved splicing events
introduce premature termination codons (PTC) and lead to
downregulation of the transcript through the process of
nonsense-mediated mRNA decay (NMD) (Baek and Green,
2005). Recent estimates from gene expression profiling sug-
gest that, in fact, as many as 10%–30% of mammalian genes
may be regulated by alternative splicing-coupled NMD (AS-
NMD) in particular contexts (Lewis et al., 2003; Mendell
et al., 2004; Weischenfeldt et al., 2012). The coordination of
AS-NMD with alternative protein isoform production generates
regulatory motifs in splicing networks. Understanding the
behavior of these individual network motifs within the context
of larger networks reveals insights into how splicing regulation
impacts cell fate decisions.Negative Autoregulation Maintains Homeostasis
When compared to a simply regulated expression system (in
which one gene product drives expression of another), a nega-
tively autoregulated system (in which a gene product feeds
back on its own production) is characterized by faster response
times and reduced cell-to-cell variability in the concentration of
a gene product. This consequently results in a single steady
state of the gene product that is buffered against variations in
transcriptional output or protein stability (Alon, 2007; Becskei
and Serrano, 2000; Nevozhay et al., 2009; Rosenfeld et al.,
2002). In Waddington’s metaphoric terms, this buffering con-
tributes to the ‘‘canalization’’ that contains a cell within the
steep valleys of the epigenetic landscape (Waddington, 1957).
It is now understood that many RNA-binding proteins (RBPs)
undergo negative autoregulation through AS-NMD (Figure 1A).
A key observation leading to this discovery was that AS-NMD
events tend to be enriched in genes encoding splicing factors
and are often ultraconserved, meaning that they fall within
regions of particularly high evolutionary conservation (Lareau
et al., 2007; Ni et al., 2007; Wollerton et al., 2004). These studies
specifically focused on AS-NMD regulation of SR proteins, a
family of serine-arginine-rich RBPs with various roles in RNA
processing and required for splicing (Long and Caceres,
2009), and hnRNP proteins, a diverse group of RBPs thought
to function most commonly as splicing repressors (Martinez-
Contreras et al., 2007). These proteins were shown to be able
to bind their own transcripts, cause splicing of the NMD variant,
and downregulate protein levels to maintain homeostatic pro-
tein expression (Lareau et al., 2007; Ni et al., 2007; Saltzman
et al., 2008). Beyond AS-NMD regulation of SR and hnRNP pro-
teins, negative autoregulation of RBPs can also occur via the
production of nonfunctional or dominant-negative protein iso-
forms (Damianov and Black, 2010). Additionally, proteins with
enzymatic activity that lack the ability to bind RNA directly can
nevertheless exert autoregulatory feedback by enzymatically
modifying RBPs. One example of this type of feedback loop is
the SR protein kinase Clk1, whose pre-mRNA undergoes
increased productive splicing in response to small-molecule in-
hibition of its own kinase activity (Ninomiya et al., 2011).Cell 159, October 23, 2014 ª2014 Elsevier Inc. 487
Figure 1. Common Motifs in Splicing Networks
(A) Negative feedback of RNA-binding proteins (RBPs) occurs when a splicing
factor regulates a nonsense-mediated decay-coupled splicing event within its
own transcript to repress its own protein expression andmaintain steady-state
expression levels.
(B) (Top) Positive feedback in splicing networks can occur through a dou-
ble-negative feedback loop. Double-negative feedback results from the
cross-regulation of two RBPs, producing two steady states each charac-
terized by the exclusive expression of one of the RBPs. (Bottom) Positive
feedback also arises through composite feedback with a splicing factor (SF)
and one or more transcription factors (TF) that results in a double-positive
feedback loop and bistability. In this case, either the SF and TF are both
expressed, or the SF and TF are both off. Red hexagons indicate premature
termination codons.
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In contrast to negative feedback, positive autoregulation is char-
acterized by slower response times and increased noise in pro-
tein expression (Maeda and Sano, 2006). Biologically, the effect
of positive feedback is to convert a graded input, such as a
growth factor signal, into a binary output, such as proliferation
versus differentiation (Becskei et al., 2001). This is known as ul-
trasensitivity. If positive feedback is strong, it can produce two
distinct steady states, or bistability, with stochastic fluctuations
in gene expression driving the switch from one steady state to
another (Alon, 2007; Blake et al., 2003). Unlike negative feed-
back, which generally returns a system to its original state after
a perturbation, positive feedback can induce memory of a tran-
sient signal by reinforcing a new cell state even after the initiating
signal has disappeared (Alon, 2007).
Splicing factors do not usually positively regulate the produc-
tive splicing of their own pre-mRNA. However, interaction be-
tween two different splicing factors can generate positive feed-
back and bistability. Double-negative feedback loops, in which
two factors repress one another, can also generate two steady
states, each with only one of the two factors expressed (Alon,
2007). As negative autoregulation of RBPs occurs so frequently,
double-negative feedback is likely to be a common motif in
splicing regulatory networks (Figure 1B). RBPs can also feature
in positive feedback loops alongside transcription factors, for
example, during the regulation of developmental decisions
(Figure 1B). A recent study investigated the role of positive feed-
back between OCT4, SRSF2, and the methyl-CpG-binding
protein MBD2 in determining the switch between pluripotency
and differentiation of embryonic stem cells (ESCs). Here, the
ESC master transcription factor OCT4 drives expression of the
splicing factor SRSF2, which generates an isoform of MBD2
that promotes OCT4 expression. If SRSF2 expression is suffi-
ciently decreased, however, MBD2 is spliced to produce an
isoform that represses expression of core ESC transcription fac-
tors. This composite positive feedback loop therefore maintains
pluripotency in the first instance and helps to drive differentiation
in the second, based on the dosage of the components within
the network (Lu et al., 2014). Similarly, the neuronal splicing regu-
lator nSR100 participates in a positive feedback loop with REST,
a transcriptional repressor of neurogenesis. In the presence of
nSR100, REST is spliced to produce an isoform with greatly
diminished repressive activity. As nSR100 is itself repressed by
REST, a differentiated cell state characterized by high nSR100
activity, and low REST activity is reinforced through positive
feedback (Raj et al., 2011).
Cross-Regulation Tunes Steady States
The steady-state expression level of a gene undergoing nega-
tive autoregulation tends toward the value of its repression
threshold, which is the concentration of the gene product
needed to repress its production by 50% (Alon, 2006).
We might consequently predict that splicing factors that are
negatively autoregulated would maintain similar steady-state
expression levels across tissues, regardless of transcriptional
activity. Conversely, RBP expression patterns do indeed
show cell type specificity (de la Grange et al., 2010; Grosso
et al., 2008), implying that additional posttranscriptional regula-
tory inputs must influence steady state. On an evolutionary
Figure 2. RNA-Binding Protein Cross-
Regulation in Splicing Networks
(A) Model for the cross-regulation of an autor-
egulatory poison exon by Rbfox2. Binding of
Rbfox2 inhibits inclusion of the poison exon (red
hexagon indicates premature termination codon),
leading to a higher steady-state expression level
of the autoregulated protein in the presence of
Rbfox2.
(B) Rbfox2 and Ptbp2 function in a splicing
cascade during neuronal differentiation. Rbfox2
directly regulates a subset of targets involved in
cytoskeletal organization. In addition, inhibition of
autoregulatory splicing of Ptbp2 by Rbfox2 leads
to Ptbp2 upregulation. Ptbp2, either in conjunction
with Rbfox2 or independently, regulates the
splicing of several genes involved in adherens
junction formation. Together, these primary and
secondary targets of Rbfox2 contribute to the
specification of neural progenitor fate (Jangi et al.,
2014; Licatalosi et al., 2012).timescale, the repression threshold and consequently the
steady-state level can be altered by mutation, for example, by
strengthening or weakening the binding site of a transcription
factor at its own promoter. Tissue-to-tissue variation, however,
cannot be explained by mutation. Moreover, as AS-NMD
events within RBPs tend to be deeply conserved (Lareau
et al., 2007; Ni et al., 2007), variations in RBP gene expression
among species are unlikely to have arisen from differences in
the strength of RBP binding to its transcript. Instead, extensive
cross-regulation between RBPs may be one mechanism that
alters steady-state RBP expression across cell types and
across species. For example, splicing of an autoregulated poi-
son cassette within one RBP can be competitively inhibited by
the binding of a second RBP. This raises the effective concen-
tration of the first RBP necessary for autoregulation and results
in its increased steady-state expression in the presence of the
second RBP. Negative autoregulation thus likely cooperates
with cross-regulation to ensure robust and tunable RBP expres-
sion patterns.
Data from a number of recent studies support the model that
cross-regulation of RBP negative feedback modulates splicing
networks while maintaining their stability. We recently identified
thousands of in vivo Rbfox2 binding sites and hundreds of
Rbfox2-regulated splicing events across the mouse ESC tran-
scriptome using iCLIP and RNAseq. From these parallel ap-
proaches, we identified a large class of Rbfox2-regulated
splicing events that are rendered silent by NMD. A significant
fraction of these NMD splicing events fell in the previously
described category of conserved autoregulatory splicing events
within RBPs (Lareau et al., 2007; Ni et al., 2007). Cross-regulation
of this autoregulatory splicing by Rbfox2 set the efficacy ofCell 159,autoregulation and thus the steady-state
expression of the gene (Figure 2A).
This suggested that Rbfox2 tunes the
autoregulation and gene expression of
a network of RBPs and that changes
in Rbfox2 expression activate direct
Rbfox2-dependent splicing changes as
well as a cascade of secondary splicingchanges (Jangi et al., 2014). These events, together, define the
complete Rbfox2 splicing regulatory network.
Cross-regulation of autoregulatory splicing has emerged as a
common motif in several other splicing networks. Two members
of the hnRNP family of splicing regulators, hnRNP L and hnRNP
L-like, have been shown to bind their own and each other’s tran-
scripts to regulate gene expression through AS-NMD (Ross-
bach et al., 2009). A genome-wide analysis of hnRNP binding
and activity in human 293T cells revealed a high frequency of
cross-regulation between many hnRNP family members,
including the regulation of several events previously shown to
be associated with NMD (Huelga et al., 2012). More generally,
hnRNP-bound transcripts were significantly enriched for RNA
processing genes; 70% of all RBP transcripts were bound by
at least one hnRNP, with greater than 25% of these showing ev-
idence of gene expression or splicing regulation (Huelga et al.,
2012). Similarly, the core spliceosomal protein SmB/B0 autore-
gulates its expression through AS-NMD (Saltzman et al.,
2008). Depletion of SmB/B0 in human tissue culture cells led
to widespread changes in splicing and expression of RBPs in
a manner attributable to AS-NMD (Saltzman et al., 2011).
CLIP signal enrichments of the RBP FUS and the SR protein
Srsf3 in highly conserved introns of other RBPs suggest that
this is a general feature of splicing networks (A¨nko¨ et al.,
2012; Nakaya et al., 2013). Such interconnected networks
may serve to stabilize splicing patterns within a particular
cellular condition.
Signal Amplification in Splicing Cascades
Cross-regulated splicing events, like transcription factors and
signaling components, can be integrated into cascades to
achieve multiple responses to different inputs. CLIP andOctober 23, 2014 ª2014 Elsevier Inc. 489
transcriptome analysis following changes in RBP activity that
identified directly bound splicing targets also identified many
secondary or indirect targets that likely arise from changes in
expression of the primary RBP targets (Huelga et al., 2012;
Jangi et al., 2014; Saltzman et al., 2011). One biological func-
tion of this effect is to amplify the original signal—in this
case, the change in expression or activity of the RBP at the
top of the cascade—while maintaining robustness against sto-
chastic fluctuations in gene expression. Such a mechanism
may determine splicing changes during the establishment of
neuronal precursors in the developing brain. Here, the increase
in Rbfox2 expression likely contributes to the increased ex-
pression of Ptbp2 through suppression of its autoregulatory
AS-NMD. Several direct targets of Ptbp2 in mouse neocortex
are also indirect targets of Rbfox2 in embryonic stem cells
(Jangi et al., 2014; Licatalosi et al., 2012). This suggests that
Rbfox2-dependent upregulation of Ptbp2 expands and rein-
forces the Rbfox2 splicing network that plays an integral role
in the specification of neuronal lineages (Gehman et al., 2012;
Jangi et al., 2014; Licatalosi et al., 2012) (Figure 2B). In this
manner, a ‘‘master splicing regulator’’—positioned at the top
of a splicing cascade—could play a critical role in the determi-
nation of cell fate.
Master Splicing Regulators and Cell Identity
Studies in the definition of cell identity have revealed that the
expression of a relatively small number of transcription factors,
termed master transcription factors, can initiate commitment
along a diverse array of developmental lineages (Young, 2011).
Characterization of splicing changes across tissues (Merkin
et al., 2012) as well as RNA-protein interaction maps (Witten
and Ule, 2011) have raised the intriguing possibility that an anal-
ogous subset of master splicing regulators exists among splicing
factors.
We propose that a putativemaster splicing regulator plays one
or both of two critical roles in the implementation of a genetic
program. First, the factormay be required for the proper differen-
tiation or specification of a cell type. These factors are likely to be
expressed in a tissue-specific manner. In the absence of the
master splicing regulator, differentiation would be incomplete
due to the misregulation of its splicing network. Conversely,
ectopic expression of a master splicing regulator in a cell type
where it is not normally expressed may drive the cell toward
the phenotype of a cell in which it is normally expressed. Such
master splicing regulators involved in lineage specification may
generate switch-like behavior by directing splicing networks
that contain positive feedback loops. Second, once a cell is
committed to a lineage, a master splicing regulator may be
required for maintaining homeostasis. This role probably re-
quires secondary splicing regulators acting downstream of the
master regulator to be negatively autoregulated, thus buffering
against variations in the cellular environment. Though master
splicing regulators involved in maintaining cell identity may again
be lineage specific, the secondary splicing factors that they
regulate, such as SR proteins and hnRNPs, may be ubiquitously
expressed. Direct and indirect targets of homeostatic master
splicing factors are likely to be functionally related, allowing for
the regulation of specific cell functions.490 Cell 159, October 23, 2014 ª2014 Elsevier Inc.Potential master splicing factors are likely to be highly regu-
lated, such that their splicing networks are activated only in the
correct settings. In order to perturb a stable splicing network
sufficiently to transition to a new state, initiating signals would
have to arise outside of the network itself. These signals are
thus likely to be transcriptional, translational, posttranslational,
or otherwise splicing independent. The variousmodes of splicing
factor activation may have distinct effects on the kinetics and
reversibility of the corresponding change in splicing network.
Moreover, a master splicing factor may have dynamic expres-
sion patterns that vary over a range that is not limited by negative
feedback. For example, transcriptional activation of a master
splicing factor gene would steadily increase its expression and
activity until reaching the threshold of autoregulation, with its
splicing network maximally activated at this threshold.
Lineage-Specifying Splicing Cascades
Several examples of RBPs functioning asmaster regulatory hubs
driving broad splicing networks during development can be
found in the literature. In some of these cases, autoregulation,
cross-regulation, and feedback play critical roles in initiating
robust and dynamic splicing cascades with distinct outcomes.
Although candidate master RBPs frequently function down-
stream of larger transcriptional programs, several of these sys-
tems also rely on AS regulation of transcription factors. The
evidence presented below suggests that through this interplay
of transcriptional and posttranscriptional effects, the activation
of key RBPs may be necessary and even sufficient to establish
cell identity. Here, we discuss instances and properties of
splicing networks driven by master splicing regulators in the
context of differentiation.
Drosophila Sex Determination
The up- or downregulation of a critical RBP—most likely one that
is expressed in a tissue-restricted manner—could initiate a
splicing network and downstream gene expression changes
that lead to a stable change in cell identity. Perhaps the best un-
derstood and most remarkable example of a bistable splicing
regulatory cascade dependent on autoregulation and cross-
regulation is the Drosophila melanogaster somatic sex determi-
nation pathway (Figure 3). Here, sex-specific expression of the
splicing repressor Sex Lethal (Sxl) specifies female development
through activation of the RBP Transformer (Tra) and repression
of male-specific lethal 2 (Msl2) (Schu¨tt and No¨thiger, 2000).
Sxl, themaster splicing regulator at the top of the sex-determina-
tion pathway, is unproductively spliced in developing male flies
(Bell et al., 1991). During early embryogenesis, a transcriptional
signal determined by the ratio of X chromosomes to autosomes
(X:A) transiently activates an upstream Sxl promoter in female
flies. The resulting transcript encodes active Sxl protein (Keyes
et al., 1992). Active Sxl reinforces productive splicing from the
constitutive downstream promoter in a positive feedback loop
in females, whereas in males, the lack of active Sxl leads to
continual production of nonfunctional Sxl. A key target of Sxl is
the SR protein Tra, which is transcribed in both sexes but is
only productively spliced in females in an Sxl-dependent manner
(Sosnowski et al., 1989). Tra in turn regulates the splicing of two
transcription factors, Fruitless (Fru) and Doublesex (Dsx), result-
ing in default male-specific isoforms in the absence of Tra and
Figure 3. Bistability in Drosophila Sex
Determination
The Drosophila sex determination pathway initi-
ates a cascade of splicing events within RNA
binding proteins and transcription factors that
regulates sexual dimorphism. The master regu-
lator Sxl drives the female-specific isoform of Tra,
which generates female-specific isoforms of the
transcription factors Dsx and Fru. Positive feed-
back loops are indicated as bold arrows. Red
hexagon indicates premature termination codon.female-specific isoforms in its presence (Hertel et al., 1996;
Lynch and Maniatis, 1996; Tian and Maniatis, 1993). Tra has
also been suggested to positively feed back on Sxl splicing,
further stabilizing the female differentiation program (Siera and
Cline, 2008). In parallel, Sxl targets the dosage compensation
regulator Msl2 to cause intron retention and a block in translation
in females, whereas a functional protein is produced in males
(Bashaw and Baker, 1995; Zhou et al., 1995). The downstream
transcriptional regulators Msl2, Fru, and Dsx establish much of
the sexual dimorphism in somatic tissues (Coschigano andWen-
sink, 1993). Although this Drosophila pathway is not conserved
among insects, splicing-dependent positive feedback is a recur-
ring theme in insect sex determination, suggesting that the use of
a splicing cascade confers an evolutionary advantage in this
bistable system (Salz, 2011).
MBNL1 and Cellular Reprogramming
Analogous splicing cascades with such distinct phenotypic con-
sequences have yet to be characterized in mammalian systems.
Yet several recent reports have demonstrated that altering the
expression of individual splicing factors can prime cells toward
a different cell state. Splicing changes occurring during meso-
dermal differentiation correlate with the activity of the MBNL
family of splicing regulators (Venables et al., 2013). More caus-
ally, in human and mouse fibroblasts, knockdown of MBNL1 in-
creases the efficiency of reprogramming to iPSCs, whereas
overexpression in human ESCs results in mesodermal splicing
patterns (Han et al., 2013). The effect on reprogramming has
been primarily attributed to MBNL1-dependent splicing of the
transcription factor FOXP1, of which the ES-specific isoform
(FOXP1-ES) represses differentiation-specific genes and acti-
vates key pluripotency genes due to an altered DNA binding
domain (Gabut et al., 2011). Importantly, the increased re-
programming efficiency caused by MBNL1 knockdown is not
phenocopied by overexpression of FOXP1-ES, implying that
additional targets of MBNL1 are involved in this process (Gabut
et al., 2011; Han et al., 2013). During cardiomyocyte maturation,
MBNL1-dependent splicing changes are enriched for spliceoso-
mal genes, and gene expression changes across this transition
are enriched for components of the splicing machinery (Giudice
et al., 2014). We can speculate that, although a subset of splicingCell 159,changes during these developmental
transitions are likely direct targets of
MBNL1, many of the events attributed
to MBNL1 regulation may, in fact, arise
from MBNL1-dependent modulations in
the expression of other splicing compo-nents. These splicing cascades not only amplify the signal
initiated by MBNL1, but may also increase robustness via the
modulation of autoregulated RBPs.
T Cell Activation
Changes in the levels of a master splicing regulator can also
trigger an irreversible transition between steady states along a
single lineage. During T lymphocyte activation, the transmem-
brane receptor CD45 undergoes a splicing switch that has
been suggested to initiate signaling through antigen receptors
(Holmes, 2008). The activity of hnRNPLL is necessary and suffi-
cient for the CD45 splicing switch, as well as for several other
splicing events associated with hematopoietic cell differentiation
and activation (Oberdoerffer et al., 2008; Topp et al., 2008). As a
result, hnRNPLL has been hypothesized to be amaster regulator
of T cell activation (Holmes, 2008). hnRNPLL is rapidly upregu-
lated upon stimulation of naive T cells in a manner consistent
with transcriptional activation (Oberdoerffer et al., 2008). In
accordance with the cross-regulation observed in other splicing
regulatory networks, several SR and hnRNP proteins containing
AS-NMD cassettes undergo upregulation in two temporally
distinct waves (Ip et al., 2011). Although hnRNPLL upregulation
does not initiate a switch-like response as with Drosophila sex
determination, it is likely that a cascade of splicing and transcrip-
tional changes are sustained to produce a new, stable T cell state
after a transient initiating transcriptional signal.
Splicing Switches by Opposing RBPs
A more common scenario in mammalian systems may be
the toggling of splicing networks by RBPs that are expressed
in a mutually exclusive manner between two conditions. The
MBNL1 expression network that becomes activated during car-
diac differentiation, for example, is likely opposed by an embry-
onic CELF1 network (Kalsotra et al., 2008). In the context of
epithelial-mesenchymal transitions, the expression of epithelial
splicing regulatory proteins 1 and 2 is quite tightly restricted to
differentiated epithelial cell types. In contrast, the splicing pat-
terns of less differentiated basal or mesenchymal cell types
bear a signature of RBFOX2. Depletion of RBFOX2 or exogenous
expression of ESRP1 in human mesenchymal breast cancer
cells causes a partial reversion to an epithelial phenotype, sug-
gesting that these factors and their targets play critical opposingOctober 23, 2014 ª2014 Elsevier Inc. 491
roles in defining epithelial and mesenchymal cell states (Shapiro
et al., 2011).
A particularly well-characterized example of mutual exclusivity
in splicing factor expression is found in the PTBP1/PTBP2 switch
during neuronal differentiation. The neuronal splicing regulator
PTBP2 is lowly expressed in most tissues and is upregulated
at the protein level in neurons. The PTBP2 transcript contains
an alternative exon that triggers NMD when skipped; inclusion
of the exon requires positive transacting factors such as
nSR100 in neurons, whereas repression is mediated by PTBP1
in undifferentiated cells (Calarco et al., 2009; Wollerton et al.,
2004). Upon miRNA-mediated downregulation of PTBP1 during
neuronal differentiation, the negative regulation of PTBP2 is
relieved, leading to a switch from a PTBP1-driven to a PTBP2-
driven AS network (Boutz et al., 2007; Makeyev et al., 2007;
Spellman et al., 2007;Wollerton et al., 2004). Interestingly, deple-
tion of PTBP1 in fibroblasts is sufficient for PTBP2 induction and
neuronal trans-differentiation, arguing that PTBP1 is a master
regulator of the undifferentiated cell state (Xue et al., 2013). It re-
mains to be seen whether PTBP2 also regulates the AS-NMD
event present in the PTBP1 transcript (Wollerton et al., 2004),
as this would result in a double-negative feedback loop speci-
fying neuronal versus nonneuronal lineages. Such dynamic regu-
lation of otherwise stable splicing networks by opposing factors
may be a common feature of diverging developmental programs.
Homeostatic Splicing Networks
Another function of a master splicing factor is to reinforce cell
identity, for example, by regulating a specific cell function or
by controlling homeostatic splicing events. These factors may
not be required to specify the cell’s lineage but may be required
to function within and respond to its environment. Master
splicing regulators acting in this context are likely to have targets
that work together to form a coherent cellular response. Homeo-
static RBPsmay also be important on short timescales. As intron
removal can function as a rate-limiting step in gene expression
(Bhatt et al., 2012), an RBP’s direct targets could be rapidly
spliced upon its activation. Such temporal properties may be
critical in mediating the transient and homeostatic responses
discussed below.
Nova1/2 Neural Splicing Networks
One of the best-characterized tissue-restricted splicing net-
works is regulated by the Nova proteins, Nova-1 and Nova-2,
exclusively in neurons. Nova-1 and Nova-2 exhibit largely
nonoverlapping patterns of expression in different regions of
the brain (Yang et al., 1998). Nova-1 null mice are born phenotyp-
ically normal but die soon after birth due to apoptosis of neurons
of the hindbrain and ventral spinal cord, implying a survival role
within differentiated neurons (Jensen et al., 2000). As with
many splicing regulators, Nova proteins recognize a short
sequence motif (in this case, YCAY) to regulate either exon inclu-
sion or skipping, depending on the location of binding with
respect to the regulated exon (Ule et al., 2006). Integrating this
RNA map with splicing changes observed in Nova knockout
mouse brains identified 700 Nova-dependent splicing targets
(Zhang et al., 2010). Many of these targets are involved in regu-
lating synapse activity and axonal guidance (Ule et al., 2005). A
number of Nova targets have also been proposed to interact492 Cell 159, October 23, 2014 ª2014 Elsevier Inc.with one another, suggesting that they may comprise a coherent
network mediating synaptic plasticity (Ule et al., 2005). In addi-
tion, the involvement of Nova-2 targets in long-term potentiation
has been suggested to fine-tune the kinetics and magnitude of
neuronal excitability (Huang et al., 2005). These studies implicate
the Nova proteins in the maintenance of a critical splicing
network essential for neuronal survival and for controlling syn-
apse activity. The regulation of functionally related genes by a
single family of RBPs to reinforce and refine cell identity may
be a hallmark of master splicing factors.
Transient Activation of Rbfox Splicing Networks
Posttranslational modification of RBPs appears to play a critical
role in establishing short-lived or reversible splicing networks.
Although at least one Rbfox protein is expressed in a large num-
ber of tissues, differential activity of each factor may allow the
Rbfox network to be regulated by unique signals in each tissue.
In the brain, Rbfox1 and Rbfox2 show nonredundant splicing ac-
tivity despite being expressed in many of the same neuronal cell
types (Gehman et al., 2012). This is consistent with different
modes of regulation for each Rbfox protein. For example,
Erk1/2 activation by growth factor stimulation results in rapid
phosphorylation of Rbfox2 in many cell types (M.J. and P.A.S.,
unpublished data; Carlson et al., 2011). If such posttranslational
modification results in differential localization or association with
the splicing machinery, it is possible that the Rbfox2 splicing
network could be toggled by growth factor signaling. In contrast,
Rbfox1 localization and consequent splicing activity are tran-
siently altered in response to neuronal depolarization. This
change is self-limiting, as the localization change is reversed
by an autoregulatory splicing event that antagonizes the effect
of depolarization (Lee et al., 2009). No analogous shift in localiza-
tion has been demonstrated for Rbfox2. Thus, given that each
Rbfox protein may respond differently to extracellular, splicing-
independent signals andmay also have unique binding partners,
they could potentially regulate nonoverlapping, reversible
splicing networks in distinct contexts. This dynamic may be
common to splicing factors that exist in paralogous isoforms,
such as MBNL, CELF, and NOVA proteins.
Splicing-Mediated Stress Responses
Homeostatic splicing networks have been implicated in coordi-
nating rapid responses to a variety of stresses. A number of
groups have reported the existence of a subset of introns with
delayed splicing that seem to play a key part in this response.
These introns are removed posttranscriptionally, after all other
introns in the transcript have been removed, prior to export
into the cytoplasm. Whereas initial studies focused on one or
two specific introns, more recent work suggests that intron
‘‘detention’’ is a regulatory motif within larger gene networks
(Bhatt et al., 2012; Denis et al., 2005; Hao and Baltimore, 2013;
Ninomiya et al., 2011). In this manner, a reserve of otherwise
completely spliced and polyadenylated messages that still
contain one or two introns serves as a buffer, allowing the coor-
dinated splicing and export of a large number of genes with pre-
cise kinetics upon receipt of a signal. This mechanism likely
serves as a splicing-regulated positive counterpoint to the nega-
tive feedback enabled by AS-NMD, as activating splicing in
response to signals could increase the amount of gene product
available. The emerging evidence discussed below indicates
that detained introns are involved in rapidly correcting deviations
from homeostasis caused by cellular stressors.
During the splicing cycle, SR proteins undergo sequential
phosphorylation and dephosphorylation mediated by the SRPK
and Clk kinases and protein phosphatases (Mermoud et al.,
1994; Roscigno and Garcia-Blanco, 1995). Through a mecha-
nism yet to be defined, hyperosmotic stress and heat shock
inhibit the activity of Clk1/4, leading to SR protein dephosphory-
lation and rapid splicing of SR protein-bound detained introns.
One of the transcripts undergoing stress-dependent maturation
is that encoding Clk1 itself. Detained introns surrounding a
frame-preserving cassette exon in the Clk1 transcript are rapidly
removed, thus re-establishing homeostatic levels of Clk kinase
activity (Ninomiya et al., 2011). Beyond this autoregulatory
loop, direct inhibition of Clk1/4 leads to expression changes of
several splicing factors, presumably due to increased splicing
of AS-NMD events within RBPs cross-regulated by SR proteins,
and activation of the p53 stress response (P.A.S., unpublished
data). These observations suggest that a large posttranscrip-
tional regulatory network may be responsible for mediating a
rapid and self-limiting cascade of transcriptome changes in
response to stress signals. Although not an RBP, Clk1 can be
classified as the master splicing regulator in this context. Inter-
estingly, a significant fraction of genes that are differentially
spliced upon UV-induced DNA damage encode the NMD iso-
forms of RBPs (Ip et al., 2011). It is possible that intron detention
is playing a similar role in AS during DNA damage as during heat
shock or hyperosmotic stress. Determining whether splicing-
dependent responses are a common theme within stress re-
sponses will consolidate the role of splicing in the maintenance
of homeostasis.
Master Splicing Regulators in Disease
Evidence for RBPs playing a critical part in determining cell state
comes from pathology caused by changes in RBP activity.
Though several genetic diseases have been attributed to muta-
tions in cis that disrupt splicing factor binding sites within critical
disease genes, many arise from the altered function of trans-
acting splicing factors. Such disorders tend to have pleiotropic
effects due to the dysregulation of entire posttranscriptional
networks, thus shedding light on the targets regulated by the
affected splicing factors in normal physiology. Disorders result-
ing in RBP dysfunction can be broadly categorized into RBP
loss of function or toxic RNA gain of function and can be in-
herited, arise from autoreactivity, or develop in the context of
cancer (Cooper et al., 2009). For example, the genetic disorder
spinal muscular atrophy is themost frequent genetic cause of in-
fant mortality and occurs due to loss of the SMN1 gene, encod-
ing a protein involved in snRNP assembly. Although SMN1 is
ubiquitously expressed, pathology is confined mainly to motor
neurons and muscle, indicative of a cell-type-specific sensitivity
to an altered splicing regulatory network (Crawford and Pardo,
1996). Myotonic dystrophy type I is caused by an expanded
CUG repeat in the first exon of the geneDMPK. This results in nu-
clear sequestration of MBNL proteins, which bind CUG repeat
hairpins, and subsequent disruption of the MBNL splicing
network across several tissues (Wang et al., 2012). In parallel,
CUG repeat expansion leads to activation of PKC signalingand hyperphosphorylation and stabilization of CELF proteins,
further contributing to splicing dysregulation (Kuyumcu-Martinez
et al., 2007). Recently, the role of apparently constitutive splicing
regulators in myelodysplastic syndromes and acute myelocytic
leukemia has come to the forefront. Recurrent mutations in
Sf3b1, U2af35, and other splicing factors in these syndromes
have suggested that the regulation of a specific splicing network
influences cell survival and proliferation in hematopoietic line-
ages (Yoshida et al., 2011). Such dysregulation or loss of specific
splicing regulators in particular contexts argues for the establish-
ment and regulation of broad biological networks by a single
upstream splicing factor.
Identifying Novel Master Splicing Regulators
To expand upon the studies discussed here, how can we identify
the master splicing regulators of a particular cell state? The input
signals that activate splicing networks may provide key insights
into which factors are contributing most strongly to the network.
As proposed here, these inputs may frequently be posttransla-
tional or transcriptional. Though transient RBP-dependent
changes in cell state are crucial for normal physiology, it has
proven to be difficult to identify RBP targets of signaling path-
ways (Heyd and Lynch, 2011). Here, we will focus on identifying
the transcriptional inputs into splicing networks—in particular,
those within irreversible developmental programs.
The emerging wealth of data in transcriptional networks af-
fords a tractable approach to identify master splicing regulators
in diverse cell systems. It was recently shown that master tran-
scription factors bind and regulate a subset of 250 large tran-
scriptional enhancer regions, termed super-enhancers, within
most cell types (Hnisz et al., 2013). The genes proximal to these
super-enhancers are enriched for key cell state determinants,
including lineage-specific transcription factors (Hnisz et al.,
2013;Whyte et al., 2013). Beyond transcription factors, however,
many additional genes driven by super-enhancers are likely to
initiate and maintain critical processes during differentiation.
The subset of tissue-specific splicing factors activated by su-
per-enhancers may fit these criteria. Specifically, we propose
that super-enhancer-activated splicing factors could directly
and rapidly impact the cellular transcriptome as master splicing
regulators. In the cases in which RBPs are among the primary
targets of master transcription factors, it is possible that the
ectopic activation of such master splicing regulators is neces-
sary and sufficient to substantially alter cell identity.
Transcriptional Super-Enhancers at RBP Genes
We predict that, as with master transcription factors, one to four
master splicing factors may be transcriptionally controlled in any
particular cell type. Indeed, across a panel of 86 human tissues
and cell lines, hierarchical clustering by the presence of a su-
per-enhancer near an RBP gene separates samples largely by
tissue type, with approximately four to five RBP genes associ-
ated with a super-enhancer in each cell type (M.J. and P.A.S.,
unpublished data; Hnisz et al., 2013). Conversely, individual
RBPs may be activated by super-enhancers across multiple tis-
sues. For example, consistent with a suggested role in initiating
and maintaining irreversible splicing networks during differentia-
tion, the splicing factor MBNL1 is marked with a super-enhancer
across several differentiated cell types, including brain, adipose,Cell 159, October 23, 2014 ª2014 Elsevier Inc. 493
Table 1. Super-Enhancer-Driven Candidate Master RNA-Binding Proteins
RNA-Binding
Proteins Tissue Targets References
RBM24 muscle myoblasts myogenin (Jin et al., 2010; Miyamoto et al., 2009)
RBM38 skeletal muscle p21 (Jin et al., 2010; Li et al., 2010; Miyamoto et al., 2009)
RBM20 adult cardiac muscle, skeletal muscle titin (Linke and Bu¨cker, 2012)
RBFOX1 skeletal muscle F1g, a-actinin (Jin et al., 2003)
RBFOX2 epithelial cells Fgfr2, Enah, Ctnnd1, Fn1 (Shapiro et al., 2011; Venables et al., 2009)
HNRNPA0 hematopoietic stem cells Egr1/2, Gfi1 (Young et al., 2014)
MBNL1 brain, adipose, adult gastrointestinal tract FOXP1 (Gabut et al., 2011)
ZNF638/NP220 brain unknown N/Aand adult, but not fetal, gastrointestinal tract (M.J. and P.A.S.,
unpublished data; Hnisz et al., 2013).
In contrast tomaster splicing regulators, we posit that second-
ary splicing regulators would contain AS-NMD splicing events
cross-regulated by master RBPs and would be less strongly
transcriptionally modulated. Several previously identified AS-
NMD targets of Rbfox2, including Tia1, Tra2a, and Snrnp70,
lack transcriptional super-enhancers across all tissues exam-
ined but have varying expression acrossmany of these cell types
(Grosso et al., 2008; Hnisz et al., 2013; Jangi et al., 2014). These
observations support the notion that an initiating transcriptional
signal, indicated by a super-enhancer, drives expression of a
master splicing factor that further regulates a cascade of addi-
tional RBPs to establish sustained condition-specific splicing
networks. Examples of potential master splicing factors acti-
vated by tissue-specific super-enhancers are outlined in Table 1.
RBM24 and RBM38: Conserved Drivers of Myogenesis
Identification of cell-type-specific transcriptional super-en-
hancers proximal to RBPs may lead to the discovery of novel
master splicing regulators. Skeletal muscle myoblasts, for
example, possess three splicing factors that are marked with
proximal super-enhancers. One of these is CELF2, a well-stud-
ied splicing regulator that has been previously implicated in
determining muscle-specific splicing patterns (Kalsotra et al.,
2008). The remaining two are less well-characterized members
of the RRM-containing family of RBPs—RBMS3 and RBM24—
and also show no evidence of containing AS-NMD splicing
events. Little is known about the effect of RBMS3 on RNA meta-
bolism, although its primarily cytoplasmic localization implies a
role in regulating RNA stability as opposed to splicing (Jayasena
and Bronner, 2012). Interestingly, both Rbm24 and its close pa-
ralog Rbm38, which is marked with a super-enhancer in mature
skeletal muscle, have been found to regulate myogenesis, in
part, through posttranscriptional regulation of myogenin and
p21 (Jin et al., 2010; Miyamoto et al., 2009) (Figure 4). Rbm24
is a target of the muscle-specific master transcription factor
MyoD and may thus establish a posttranscriptional regulatory
network early in muscle differentiation (Li et al., 2010). Indeed,
overexpression of either Rbm24 or Rbm38 promotes murine
myogenesis, whereas loss of Rbm24 inhibits myogenesis in
both murine and Xenopus models (Jin et al., 2010; Li et al.,
2010; Miyamoto et al., 2009). The evolutionary conservation of
this pathway indicates that posttranscriptional regulation affords
particular advantageous characteristics. In addition, in support494 Cell 159, October 23, 2014 ª2014 Elsevier Inc.of the combinatorial control and coregulation that characterizes
RBP networks, it has also been speculated that Rbm38 works
cooperatively to activate Rbfox-dependent splicing specifically
in muscle (Heinicke et al., 2013; Zhang et al., 2008). Rbm24
moreover interacts with Rbfox1 by yeast two-hybrid (Lim et al.,
2006). These observations may explain the increased use of
Rbfox-dependent alternative exons in muscle in spite of similar
Rbfox expression patterns in muscle compared to several other
tissues lacking Rbfox splicing signatures (Figure 4). Master RBPs
such as Rbm24 and Rbm38 could thus have a significant contri-
bution to and may, in some cases, be sufficient for the cell-type-
specific gene expression networks thought to be driven primarily
by master transcription factors. Taken together, RBPs identified
by proximity to transcriptional super-enhancers are likely to
function as master splicing regulators upstream of broad cell-
type-specific splicing networks.
Future Perspectives
Over the past decade, high-throughput RNA sequencing tech-
nologies have advanced the study of alternative splicing from a
single-regulator, single-target approach to a more global anal-
ysis of splicing networks. The difficulty now lies in synthesizing
the complex information generated in these studies within the
conceptual framework of a biological program. The general
systems biology principles presented in this Review will aid in
the parsing of new data into homeostatic, developmental, or
as-yet undefined regulatory networks.
Identifying the master and secondary splicing regulators
driving context-specific splicing patterns is being furthered by
bioinformatics approaches. Several groups have undertaken
computational analyses that integrate RBP consensus motifs
and other RNA features with transcriptomics and RNA-protein
interaction maps to identify primary RBP contributors and tis-
sue-specific splicing parameters (Barash et al., 2010; Lim
et al., 2011; Zhang et al., 2010). These ‘‘splicing codes’’ have
made apparent that different subsets of genomically encoded
cis elements are active in different tissues, suggesting that the
balance of splicing factors expressed in a given cell type is a
primary determinant of its splicing patterns. Moving forward, it
will be critical to integrate the splicing cascades outlined here
into these splicing codes to achieve a more comprehensive
understanding of the regulatory layers that function in different
physiological contexts. Such studies will also allow for a
more quantitative definition of master splicing regulators—for
Figure 4. Master Splicing Factors in
Myogenesis
Rbm24 and Rbm28 are master RNA-binding pro-
teins in skeletal muscle differentiation and mainte-
nance. The master transcription factor MyoD
activates Rbm24 and Rbm38 in skeletal muscle
myoblasts, concurrent with E2f-dependent activa-
tion of cell proliferation and Rbm38 activation. In a
negative feedback loop that counters E2f activity,
Rbm24 and Rbm38 initiate exit from the cell cycle
by stabilization of p21. Rbm24 drives differentiation
through the stabilization of the critical myogenesis
factor myogenin. Both Rbm24 and Rbm38 control
muscle-dependent splicing in differentiated my-
otubes through the coregulation of Rbfox1 target
splicing events (Jin et al., 2010; Li et al., 2010;
Miyamoto et al., 2009; Zhang et al., 2008). (Bottom)
Rbm24 acquires an active transcriptional super-
enhancer in skeletal muscle myoblasts (yellow and
green circles) and retains the mark in differentiated
myotubes, in which the Rbm38 super-enhancer
also becomes active (Hnisz et al., 2013).example, by requiring a factor to regulate, directly and indirectly,
a minimum fraction of splicing events in a particular condition to
qualify as a master regulator.
Though a great deal of evidence reinforces the notion that
modulation of a single RBP can initiate cell state transitions,
we posit that a large supporting cast of splicing factors also plays
crucial roles in establishing and maintaining cell identity. Under-
standing the coregulation of direct and indirect splicing changes,
as well as gene expression changes arising from transcriptional
regulation, will be essential in determining the roles of both mas-
ter and secondary splicing factors in the establishment of tissue
transcriptomes. Splicing-independent roles of RBPs, such as the
regulation of mRNA localization and stability, will also need to be
addressed to define the contribution of various posttranscrip-
tional regulatory mechanisms to cell state maintenance. Once
identified within larger regulatory networks in specific cellular
contexts, modulation of master splicing factor levels could pro-
vide a more precise alternative to transcription-factor-based
cellular reprogramming and manipulation. Future genetic,
genomic, and biochemical analyses will elucidate the critical
and nuanced role of the RBP repertoire in defining gene regula-
tory networks across mammalian development.
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